论文部分内容阅读
目的 探讨射频 (RFA)治疗肝癌不同途径的合理选用。方法 41例肝癌病人分为 2组进行经皮射频 (PRFA)治疗和开腹射频 (IRFA )治疗 ,并对结果进行比较。结果 PRFA治疗 18例病人共 32个肿瘤结节 ,IRFA治疗 2 3例病人共 43个结节 ,PRFA和IRFA并发症率分别为 33.3%和 4.3% (P <0 .0 5 )。随访平均 10个月 ,PRFA组 7个病灶复发 ( 4个病人 ) ,复发率 2 1.9% ( 7/32 ) ,而IRFA组仅 1个结节复发 ,复发率 2 .3% ( 1/43,P <0 .0 2 5 )。结论 RFA治疗肝癌途径的选用应根据病变位置、结节的大小和肝硬化程度等综合考虑而定 ,IRFA并发症少 ,治疗彻底 ,效果优于PRFA。
Objective To explore the rational use of radiofrequency (RFA) in the treatment of liver cancer. Methods Forty-one cases of liver cancer patients were divided into two groups for percutaneous radiofrequency (PRFA) treatment and open radiofrequency (IRFA) treatment, and the results were compared. Results Thirty-two tumor nodules were treated with PRFA in 18 patients, and 43 nodules were treated with IRFA in 23 patients. The complication rates of PRFA and IRFA were 33.3% and 4.3%, respectively (P < 0.05). After an average of 10 months of follow-up, 7 lesions in the PRFA group relapsed (4 patients). The recurrence rate was 21.9% (7/32). In the IRFA group, only one nodule recurred with a recurrence rate of 2.3% (1/43). P <0. 0 2 5 ). Conclusion The choice of RFA in the treatment of liver cancer should be based on comprehensive considerations such as the location of the lesion, the size of the nodule, and the degree of cirrhosis. IRFA has fewer complications and complete treatment, and the effect is better than PRFA.